as the world's leading and most diverse derivatives marketplace, cme group (www.cmegroup.com) is where the world comes to manage risk. cme group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. cme group brings buyers and sellers together through its cme globex® electronic trading platform and its trading facilities in new york and chicago. cme group also operates cme clearing, one of the world’s leading central counterparty clearing provider in the world, which offers clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through cme clearport®. these products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.
Company profile
Ticker
CME
Exchange
Website
CEO
Terrence Duffy
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CHICAGO MERCANTILE EXCHANGE HOLDINGS INC
SEC CIK
Corporate docs
Subsidiaries
Board of Trade of the City of Chicago, Inc. • BrokerTec Americas LLC • BrokerTec Europe Limited • BrokerTec Holdings Inc. • Chicago Mercantile Exchange Inc. • Chicago Mercantile Exchange Korea Inc. • CME Amsterdam B.V. • CME Consulting (Beijing) Co. Ltd. • CME Finance Holdings Limited • CME Global Marketplace Inc. ...
IRS number
364459170
CME stock data
Latest filings (excl ownership)
DEF 14A
Definitive proxy
18 Mar 24
8-K
Departure of Directors or Certain Officers
7 Mar 24
10-K
2023 FY
Annual report
28 Feb 24
8-K
CME Group Inc. Reports Fourth-Quarter and Full-Year 2023 Financial Results
14 Feb 24
8-K
Departure of Directors or Certain Officers
6 Dec 23
8-K
Regulation FD Disclosure
29 Nov 23
8-K
Departure of Directors or Certain Officers
13 Nov 23
10-Q
2023 Q3
Quarterly report
1 Nov 23
8-K
CME Group Inc. Reports Third-Quarter 2023 Financial Results
25 Oct 23
8-K
Regulation FD Disclosure
21 Sep 23
Transcripts
CME
Earnings call transcript
2023 Q4
14 Feb 24
CME
Earnings call transcript
2023 Q3
25 Oct 23
CME
Earnings call transcript
2023 Q2
26 Jul 23
CME
Earnings call transcript
2023 Q2
26 Jul 23
CME
Earnings call transcript
2023 Q1
26 Apr 23
CME
Earnings call transcript
2022 Q4
8 Feb 23
CME
Earnings call transcript
2022 Q3
26 Oct 22
CME
Earnings call transcript
2022 Q2
27 Jul 22
CME
Earnings call transcript
2022 Q1
27 Apr 22
CME
Earnings call transcript
2021 Q4
9 Feb 22
Latest ownership filings
5
Charles P Carey
15 Mar 24
4
Jack J Tobin
8 Mar 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
BlackRock Inc.
26 Jan 24
4
WILLIAM R SHEPARD
19 Jan 24
4
TERRENCE A DUFFY
2 Jan 24
4
WILLIAM R SHEPARD
29 Dec 23
4
Bryan T Durkin
12 Dec 23
144
Notice of proposed sale of securities
12 Dec 23
4
Derek Sammann
5 Dec 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 89.50 bn | 89.50 bn | 89.50 bn | 89.50 bn | 89.50 bn | 89.50 bn |
Cash burn (monthly) | 8.54 bn | 4.38 bn | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 48.05 bn | 24.66 bn | n/a | n/a | n/a | n/a |
Cash remaining | 41.45 bn | 64.84 bn | n/a | n/a | n/a | n/a |
Runway (months of cash) | 4.9 | 14.8 | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
85.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1185 |
Opened positions | 125 |
Closed positions | 78 |
Increased positions | 445 |
Reduced positions | 413 |
13F shares | Current |
---|---|
Total value | 61.57 tn |
Total shares | 306.88 mm |
Total puts | 1.61 mm |
Total calls | 1.61 mm |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 33.24 mm | $6.65 tn |
BLK Blackrock | 23.24 mm | $4.65 tn |
JPM JPMorgan Chase & Co. | 17.73 mm | $3.55 tn |
STT State Street | 15.54 mm | $3.11 tn |
Capital World Investors | 13.42 mm | $2.69 tn |
Capital International Investors | 12.69 mm | $2.54 tn |
Capital Research Global Investors | 9.00 mm | $1.80 tn |
Geode Capital Management | 7.39 mm | $1.48 tn |
BK Bank Of New York Mellon | 7.09 mm | $1.42 tn |
Parnassus Investments | 5.64 mm | $1.13 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Mar 24 | Tobin Jack J | Common Stock Class A | Gift | Dispose G | No | No | 0 | 72 | 0.00 | 23,062 |
18 Jan 24 | Shepard William R | Common Stock Class A | Buy | Acquire P | Yes | No | 202.44 | 1,331.199 | 269.49 k | 253,060.465 |
18 Jan 24 | Shepard William R | Common Stock Class A | Buy | Acquire P | No | No | 202.44 | 58.686 | 11.88 k | 2,321.631 |
31 Dec 23 | Duffy Terrence A | Common Stock Class A | Payment of exercise | Dispose F | No | No | 210.6 | 12,366 | 2.60 mm | 82,191 |
28 Dec 23 | Shepard William R | Common Stock Class A | Buy | Acquire P | Yes | No | 210.79 | 266.472 | 56.17 k | 251,729.266 |
28 Dec 23 | Shepard William R | Common Stock Class A | Buy | Acquire P | No | No | 210.79 | 11.748 | 2.48 k | 2,262.945 |
10 Oct 23 | Charles P Carey | Class B Common Stock, Series B-4 | Sell | Dispose S | Yes | No | 216.09 | 1 | 216.09 | 0 |
9 Oct 23 | Charles P Carey | Class B Common Stock, Series B-3 | Sell | Dispose S | Yes | No | 215.76 | 1 | 215.76 | 0 |
9 Oct 23 | Charles P Carey | Class B Common Stock, Series B-1 | Sell | Dispose S | Yes | No | 215.76 | 1 | 215.76 | 0 |
6 Oct 23 | Charles P Carey | Class B Common Stock, Series B-2 | Sell | Dispose S | Yes | No | 211.93 | 1 | 211.93 | 0 |
News
CME Group, Archer-Daniels-Midland And An Athletic Apparel Company On CNBC's 'Final Trades'
18 Mar 24
Decoding 5 Analyst Evaluations For CME Gr
6 Mar 24
Argus Research Maintains Buy on CME Gr, Raises Price Target to $245
6 Mar 24
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,100 Today
27 Feb 24
General Motors, CME Group, Leidos And More On CNBC's 'Final Trades'
22 Feb 24
Press releases
CME Group Inc. Announces First-Quarter 2024 Earnings Release, Conference Call
15 Mar 24
Modest improvement in farmer sentiment, yet financial concerns loom
5 Mar 24
CME Group Reports February ADV of 29.6 Million Contracts
4 Mar 24
CME Group Executives to Present at 2024 Raymond James Annual Institutional Investors Conference
1 Mar 24
CME Group Launches Clearing Service for Mexican F-TIIE Overnight Index Swaps
20 Feb 24